ArteraAI Announces First-Ever AI-Derived Biomarker for Predicting Androgen Deprivation Therapy (ADT) Benefit in Prostate Cancer
ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, announced today t [...]
Florida medical tech company launches novel AI test for prostate cancer therapy
ArteraAI’s ‘first-ever predictive test’ helps doctors choose personalized treatment for patients Fox News Article
Can Artificial Intelligence Help Diagnose Prostate Cancer?
AI may be a medical game-changer, with the power of machine learning advancing the efficacy of prostate cancer biopsies and m [...]
Andre Esteva of ArteraAI: 5 Things I Wish Someone Told Me Before I Became A CEO
Medium’s Doug Noll spoke with the CEO of ArteraAI, Andre Esteva, to discuss his path from Stanford University to founding fou [...]
ArteraAI and ACS form collaboration to use AI for designing personalized therapy
ArteraAI and the American Cancer Society formed a collaboration focused on the development of AI-driven cancer therapy person [...]
ArteraAI and American Cancer Society Announce New Relationship
ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, and the American [...]
Fierce Healthcare Fundraising Tracker—Cancer-testing startup Artera banks $90M; ‘Radiology in a Box’ developer OXOS Medical nabs $23M
The maker of AI-based prognostic cancer tests is led by its flagship offering ArteraAI Prostate Test. The test is at the fore [...]
ArteraAI Launches with $90 Million in Funding to Personalize Cancer Therapy With Multimodal AI
ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, launched publicly [...]
MMAI Model More Accurately Predicts Outcomes of High-Risk Prostate Cancer
Jessica Nye from Cancer Therapy Advisor discusses key findings, presented by Daniel Spratt, MD at ASCO GU 2023, demonstrating [...]